Cole Ikkala serves as vice president of strategic capital at Paragon Biosciences. He focuses on capital allocation, liquidity strategy, and investment diligence and monitoring. In addition, he works with the portfolio management team, assisting with various strategic and operational initiatives of Paragon’s portfolio companies.

Cole Ikkala has held various roles in the life sciences industry with accountability for corporate strategy, business development, portfolio management, capital sourcing and operations. He previously served as senior director, business operations (neuroscience) at Radius Health where he led the acquisition and business operations of a development-stage neuroscience program. Prior to that, Mr. Ikkala served as director, business development, investor/capital sourcing, and communications at Novan, Inc. He was also a business analyst at Malin Corporation PLC, where he participated in investment activities and strategic initiatives across its portfolio companies. Mr. Ikkala has a bachelor’s degree in Managerial Economics from Union College.